tiprankstipranks
Trending News
More News >
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market

United Therapeutics (UTHR) Ratios

Compare
582 Followers

United Therapeutics Ratios

UTHR's free cash flow for Q1 2025 was $0.88. For the 2025 fiscal year, UTHR's free cash flow was decreased by $ and operating cash flow was $0.53. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.41 4.41 9.85 7.61 6.70
Quick Ratio
4.28 4.28 9.55 7.30 6.44
Cash Ratio
1.50 1.50 2.80 2.93 2.28
Solvency Ratio
0.88 0.88 0.62 0.43 0.46
Operating Cash Flow Ratio
1.22 1.22 2.34 1.96 2.34
Short-Term Operating Cash Flow Coverage
2.44 2.44 0.00 0.00 0.00
Net Current Asset Value
$ 2.37B$ 2.37B$ 2.13B$ 1.11B$ 947.40M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.10 0.13 0.15 0.17
Debt-to-Equity Ratio
0.12 0.12 0.17 0.20 0.24
Debt-to-Capital Ratio
0.10 0.10 0.14 0.17 0.19
Long-Term Debt-to-Capital Ratio
0.05 0.05 0.14 0.17 0.19
Financial Leverage Ratio
1.20 1.20 1.26 1.31 1.36
Debt Service Coverage Ratio
2.39 2.39 25.22 33.26 22.22
Interest Coverage Ratio
19.98 19.98 30.24 29.89 25.26
Debt to Market Cap
0.07 0.07 0.06 0.08 0.12
Interest Debt Per Share
16.22 16.22 18.29 18.23 18.63
Net Debt to EBITDA
-0.37 -0.37 -0.15 -0.13 0.09
Profitability Margins
Gross Profit Margin
88.94%88.94%92.42%92.73%92.71%
EBIT Margin
57.30%57.30%51.08%40.75%40.21%
EBITDA Margin
59.58%59.58%53.73%43.71%43.57%
Operating Profit Margin
50.91%50.91%50.60%32.98%40.02%
Pretax Profit Margin
54.75%54.75%49.09%35.24%43.07%
Net Profit Margin
42.31%42.31%37.56%28.23%34.71%
Continuous Operations Profit Margin
42.31%42.31%37.56%28.23%34.71%
Net Income Per EBT
77.28%77.28%76.51%80.11%80.58%
EBT Per EBIT
107.54%107.54%97.03%106.84%107.63%
Return on Assets (ROA)
13.74%13.74%12.03%9.20%11.15%
Return on Equity (ROE)
16.46%16.46%15.16%12.02%15.16%
Return on Capital Employed (ROCE)
18.62%18.62%17.18%11.43%13.83%
Return on Invested Capital (ROIC)
13.54%13.54%13.15%9.16%11.14%
Return on Tangible Assets
13.96%13.96%12.12%9.28%11.55%
Earnings Yield
9.57%9.57%5.75%4.90%7.67%
Efficiency Ratios
Receivables Turnover
8.35 8.35 8.79 8.48 9.42
Payables Turnover
45.98 45.98 35.78 32.24 26.37
Inventory Turnover
2.30 2.30 1.44 1.31 1.25
Fixed Asset Turnover
2.23 2.23 2.25 2.16 2.03
Asset Turnover
0.32 0.32 0.32 0.33 0.32
Working Capital Turnover Ratio
0.80 0.80 0.77 0.87 0.91
Cash Conversion Cycle
194.27 194.27 285.13 311.19 316.96
Days of Sales Outstanding
43.74 43.74 41.55 43.03 38.73
Days of Inventory Outstanding
158.47 158.47 253.78 279.49 292.07
Days of Payables Outstanding
7.94 7.94 10.20 11.32 13.84
Operating Cycle
202.21 202.21 295.33 322.51 330.80
Cash Flow Ratios
Operating Cash Flow Per Share
20.90 20.90 17.64 13.32 17.10
Free Cash Flow Per Share
15.97 15.97 14.59 10.63 15.76
CapEx Per Share
4.92 4.92 3.05 2.69 1.34
Free Cash Flow to Operating Cash Flow
0.76 0.76 0.83 0.80 0.92
Dividend Paid and CapEx Coverage Ratio
4.24 4.24 5.78 4.95 12.74
Capital Expenditure Coverage Ratio
4.24 4.24 5.78 4.95 12.74
Operating Cash Flow Coverage Ratio
1.40 1.40 1.00 0.75 0.94
Operating Cash Flow to Sales Ratio
0.42 0.42 0.41 0.35 0.51
Free Cash Flow Yield
7.26%7.26%5.25%4.92%10.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.45 10.45 17.40 20.39 13.03
Price-to-Sales (P/S) Ratio
4.42 4.42 6.53 5.76 4.52
Price-to-Book (P/B) Ratio
1.72 1.72 2.64 2.45 1.98
Price-to-Free Cash Flow (P/FCF) Ratio
13.77 13.77 19.06 20.32 9.63
Price-to-Operating Cash Flow Ratio
10.52 10.52 15.77 16.22 8.88
Price-to-Earnings Growth (PEG) Ratio
0.33 0.33 0.34 -2.26 -0.02
Price-to-Fair Value
1.72 1.72 2.64 2.45 1.98
Enterprise Value Multiple
7.05 7.05 12.01 13.04 10.48
Enterprise Value
9.78B 9.78B 12.49B 9.61B 6.77B
EV to EBITDA
7.05 7.05 12.01 13.04 10.48
EV to Sales
4.20 4.20 6.45 5.70 4.56
EV to Free Cash Flow
13.09 13.09 18.82 20.12 9.72
EV to Operating Cash Flow
10.00 10.00 15.57 16.06 8.96
Tangible Book Value Per Share
125.44 125.44 104.44 87.18 73.24
Shareholders’ Equity Per Share
127.88 127.88 105.42 88.17 76.81
Tax and Other Ratios
Effective Tax Rate
0.23 0.23 0.23 0.20 0.19
Revenue Per Share
49.73 49.73 42.56 37.54 33.56
Net Income Per Share
21.04 21.04 15.98 10.60 11.65
Tax Burden
0.77 0.77 0.77 0.80 0.81
Interest Burden
0.96 0.96 0.96 0.86 1.07
Research & Development to Revenue
0.18 0.18 0.17 0.32 0.24
SG&A to Revenue
0.17 0.17 0.21 0.24 0.25
Stock-Based Compensation to Revenue
0.02 0.02 0.06 0.08 0.11
Income Quality
0.99 0.99 1.10 1.26 1.47
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis